Global mRNA Vaccines Market By Clinical Trial Phase (Preclinical , Phase I , Phase II , Phase III, Commercial); By Type (Non-replicating mRNA, In vivo self-replicating mRNA, In vitro dendritic cell non-replicating mRNA vaccine); By Indication/Application (Oncology (Solid Tumors, Melanoma, Prostate cancer, Ovarian cancer, Glioblastoma, HPV + Cancer , Renal Cancer , Others ), Infectious Diseases (COVID-19 vaccine, Rabies, Lassa, yellow fever, Respirational syncytial virus, Rota, Malaria , Universal influenza , Zika virus, Multiple sclerosis (MS) , Epstein-Barr virus (EBV), HIV vaccine, Others), Rare Diseases); By Vaccine Modality (Therapeutic, TME Modulation, Prophylactic, DC Vaccine, T Cell regulation); By Route of Administration (Intravenous/Intradermal, Intratumoral, Intramuscular); By Applications (Adolescents & Pediatric, Adults); By End-User (Healthcare Facilities, Government Vaccination Campaigns, Research Facilities, Others); By Region (North America (U.S., Canada, Mexico, Rest Of North America),